ICML 2019 | CAR-T horizons in NHL

Anna Sureda, MD, PhD, Catalan Institute of Oncology, Duran I Reynals Hospital, Barcelona, Spain, gives her perspective on the emerging approaches for the use of CAR T-cell therapy in non-Hodgkin lymphoma. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.